Pharmaceutical company Wockhardt has reported a consolidated net loss of Rs 192 crore for the fourth quarter of FY12 as against profit of Rs 162 crore in the corresponding quarter of last fiscal, due to exceptional loss of Rs 450 crore during the quarter.
first published: May 22, 2012 03:21 pm
A collection of the most-viewed Moneycontrol videos.
Live: Market breadth weakens, India VIX jumps as Iran-US ceasefire hangs | Closing Bell
IEX Stock Crash Explained | CERC’s New Rule Shakes Power Market
LIVE | US Navy seizes Iranian ship; talks uncertain; Nifty 200 DMA key, bank earnings focus now!
Iran Rejects US Talks Again, Strait Of Hormuz Tensions Rise As Oil Route Risks Grow
